Management of erroneous subcutaneous injection of vincristine
- 23 August 2020
- journal article
- letter
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 61 (10), 2530-2532
- https://doi.org/10.1080/10428194.2020.1772471
Abstract
(2020). Management of erroneous subcutaneous injection of vincristine. Leukemia & Lymphoma. Ahead of Print.This publication has 7 references indexed in Scilit:
- Extravasation emergencies: state-of-the-art management and progress in clinical researchmemo - Magazine of European Medical Oncology, 2016
- Management of the extravasation of anti-neoplastic agentsSupportive Care in Cancer, 2015
- Vesicant Extravasation Part I: Mechanisms, Pathogenesis, and Nursing Care to Reduce RiskOncology Nursing Forum, 2006
- Extravasation of systemic hemato-oncological therapiesAnnals of Oncology, 2004
- Prevention and Management of Extravasation of Cytotoxic DrugsDrug Safety, 1995
- Paclitaxel-induced "recall" soft tissue injury occurring at the site of previous extravasation with subsequent intravenous treatment in a different limb.Journal of Clinical Oncology, 1994
- Hyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical resultsZeitschrift für Krebsforschung und Klinische Onkologie, 1994